Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 3

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Mar 27, 2019; 11(3): 261-272
Published online Mar 27, 2019. doi: 10.4254/wjh.v11.i3.261

Table 1 Factors possibly associated with the recurrence of hepatocellular carcinoma after liver transplantation

Related to the tumor	Related to the patient	Related to the treatment
Tumor staging	Obesity	Pretransplantation:
Vascular invasion	Viral etiology	Percutaneous tumor biopsy
Vascular invasion	HCV treatment	Percutaneous tumor biopsy
Differentiation’s grade	HCV treatment	Waiting time
	NAFLD	Bridging therapy
		Peri-transplantation:
Alpha-fetoprotein		Donor’s age
Neutrophil-lymphocyte ratio		Ischemia time
		Surgical technique
		Posttransplantation:
Enhanced uptake in PET scan		Immunosuppression
Enhanced uptake in PET scan		Adjuvant sorafenib
MRI findings with gadoxetic acid
Response to LRT

MRI: Magnetic resonance imaging; LRT: Locoregional therapy; HCV: Hepatitis C virus; NAFLD: Non-alcoholic fatty liver disease.

Citation: Filgueira NA. Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation. World J Hepatol 2019; 11(3): 261-272
URL: https://www.wjgnet.com/1948-5182/full/v11/i3/261.htm
DOI: https://dx.doi.org/10.4254/wjh.v11.i3.261

Filgueira NA. Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation. World J Hepatol 2019; 11(3): 261-272 [PMID: 30967904 DOI: 10.4254/wjh.v11.i3.261]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.